Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System
US-based medical device company Artivion has completed its acquisition of Israeli medical technology firm Endospan in a deal valued at $135 million upfront, triggered by the US Food and Drug Administration’s approval of Endospan’s NEXUS aortic graft stent system. The move formally exercises a license option that Artivion had secured under a strategic agreement signed […]
The post Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System first appeared on HHM Global | B2B Online Platform & Magazine.